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DICER1 is an enzyme that generates mature microRNAs (miRNAs), which regulate gene
expression post-transcriptionally in brain and other tissues and is involved in synaptic
maturation and plasticity. Here, through genome-wide differential gene expression survey of
post-traumatic stress disorder (PTSD) with comorbid depression (PTSD&Dep), we ﬁnd that
blood DICER1 expression is signiﬁcantly reduced in cases versus controls, and replicate this in
two independent cohorts. Our follow-up studies ﬁnd that lower blood DICER1 expression is
signiﬁcantly associated with increased amygdala activation to fearful stimuli, a neural
correlate for PTSD. Additionally, a genetic variant in the 30 un-translated region of DICER1,
rs10144436, is signiﬁcantly associated with DICER1 expression and with PTSD&Dep, and the
latter is replicated in an independent cohort. Furthermore, genome-wide differential
expression survey of miRNAs in blood in PTSD&Dep reveals miRNAs to be signiﬁcantly
downregulated in cases versus controls. Together, our novel data suggest DICER1 plays a role
in molecular mechanisms of PTSD&Dep through the DICER1 and the miRNA regulation
pathway.
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E
xposure to traumatic life events and its sequelae, such as
post-traumatic stress disorder (PTSD) and depression, are a
signiﬁcant source of suffering and impairment around the
world and major contributors to the global burden of disease1,2.
However, our understanding of biological mechanisms
underlying PTSD and depression is still incomplete. Gene
expression proﬁles reﬂect dynamic interplay between genes and
the environment and thus can provide a window into molecular
mechanisms underlying these stress-related disorders. Though
gene expression is tissue speciﬁc, expression levels of many genes
have moderate correlations between blood and other tissues,
including post-mortem brain3,4. Moreover, stress-related
transcriptomic changes in peripheral blood mononuclear cells
were paralleled by stress-related gene expression changes in the
relevant brain regions in mice5. Since it is difﬁcult to obtain brain
tissues in live human subjects, gene expression proﬁles in blood
may provide a useful surrogate to offer information on biological
mechanisms of neuropsychological disorders as well as their
effects on physical health.
PTSD with comorbid depression (referred to as PTSD&Dep
from here on) is highly prevalent among susceptible individuals
following traumatic life experiences. For example, in the Grady
Trauma Project (GTP) sample of 6863 at-risk inner city
participants with high rates of trauma exposure, the prevalence
of PTSD&Dep was 28.4%. In another instance, among the 29,486
post-9–11World Trade Center Health Registry enrolees, 4.8% had
depression only, 5.1% had PTSD only and 10.1% had PTSD&Dep
at 10 years after the September 11 disaster6. Nosologic
distinctions among different psychiatric disorders so far
have largely been based on descriptive studies and not on
neural circuits or biological mechanisms. Hence, in this study, we
aimed to increase our understanding of molecular mechanisms
underlying PTSD&Dep, a relatively common sequel of traumatic
life events.
To that end, we survey genome-wide differential gene
expression proﬁles in blood in cases of PTSD&Dep and
traumatized controls with no PTSD and no depression. Our
hypothesis is that genes differentially expressed in PTSD&Dep
inform biological pathways underlying this psychiatric pheno-
type. We ﬁnd that expression of DICER1 is signiﬁcantly reduced
in the cases relative to the controls, and this ﬁnding is replicated
in two independent cohorts. This is quite intriguing given prior
possible association of DICER1 to depression-related phenotypes
in humans and mice7,8. To follow-up on the DICER1 ﬁnding, we
perform expression quantitative trait locus (eQTL) analysis for
DICER1 and ﬁnd an eQTL, rs10144436, located in DICER1’s
three prime un-translated region (30UTR), signiﬁcantly associated
with PTSD&Dep and replicate this ﬁnding in another cohort.
Additionally, we ﬁnd that lower blood DICER1 expression is
signiﬁcantly associated with increased activation of the amygdala
to threat stimuli, a neural correlate of PTSD, in a functional
magnetic resonance imaging (fMRI) study. DICER1 is notable as
an enzyme that is central to the post-transcriptional regulation of
gene expression as it cleaves precursor microRNAs (miRNAs)
and double-stranded RNAs into mature miRNAs and short-
interfering RNAs, both of which regulate expression of thousands
of genes post-transcriptionally9. Given DICER1 functions, we
survey genome-wide differential miRNA expression proﬁles in
blood in a smaller discovery sample of PTSD&Dep and ﬁnd two
miRNAs signiﬁcantly reduced in abundance in the cases. Of
these, miR-3130-5p is also signiﬁcantly downregulated in
PTSD&Dep cases versus controls in a replication sample, and
one of its mRNA targets is upregulated in the PTSD&Dep cases.
Together, our data show that DICER1 and miRNAs are involved
in molecular mechanisms of PTSD&Dep via the DICER1 and the
miRNA regulation pathway. This stress-related DICER1 and
miRNA regulation in blood is paralleled by recent ﬁndings of
stress-related DICER1 and miRNA regulation in brain in a mouse
model8.
Results
Characteristics of the discovery cohort. There were 184 parti-
cipants in the GTP discovery cohort (Table 1). Of these, 112 were
cases of current PTSD&Dep and 72 were traumatized controls
with no current PTSD and no current depression. Speciﬁcally,
mean PTSD symptom scores among the cases and controls were
28.7 and 2.1, respectively, and mean depression scores among the
cases and controls were 28.2 and 2.7, respectively (Table 1). The
cases and controls had comparable age and proportions of men
and women (Table 1). As expected, the cases were exposed to
more traumatic life events than the controls (7.3 versus 3.8;
Table 1). In a subset of these participants (n¼ 145–150), we had
information on current alcohol and drug use disorders, bipolar
disorder and current psychotic disorder assessed by the Mini
International Neuropsychiatric Interview (MINI)10 and Structure
Clinical Interview for DSM-IV (SCID)11. More cases had
substance use disorder, psychotic disorder and bipolar disorder
than controls, but these differences did not reach statistical
signiﬁcance (Table 1). Lastly, the cases had slightly more
Table 1 | Characteristics of the GTP discovery sample of cases of PTSD&Dep and controls with no PTSD and no depression
(n¼ 184).
Characteristics Cases (n¼ 112) Controls (n¼ 72) P-value*
Age 41.9±10.7 43.3±14.9 0.28
Sex (% female) 77.7% 70.8% 0.29
Race (% African American) 91.1% 98.6% 0.04
PSSw score 28.7±9.2 2.1±2.3 o0.0001
BDIz score 28.2±10.1 2.7±2.1 o0.0001
Current substance use disordery (yes) 18.0% 9.8% 0.17
Current psychotic disorder|| (yes) 16.3% 6.8% 0.12
Bipolar disorderz (yes) 2.3% 0.0% 0.51
Number of traumatic experiences 7.3±3.8 3.4±2.8 o0.0001
BDI; Beck Depression Inventory; GTP, Grady Trauma Project; MINI, Mini International Neuropsychiatric Interview; PSS, PTSD symptom scale; PTSD, post-traumatic stress disorder; PTSD&Dep, PTSD with
comorbid depression; SCID, Structure Clinical Interview for DSM-IV.
*P values were from Wilcoxon Rank Sums or Fisher exact test.
wPSS: PTSD symptom severity score from the PSS.
zBDI: depression severity score from the BDI.
yAvailable in a subset of 150 subjects; assessed by the SCID and MINI.
||Available in a subset of 145 subjects; assessed by the SCID and MINI.
zAvailable in a subset of 148 subjects; assessed by the SCID and MINI.
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percentage of African Americans than the controls (Table 1). We
controlled for these psychiatric variables and ancestry in our
differential expression analysis as detailed below.
Genome-wide differential expression proﬁles in PTSD&Dep. In
our primary analysis, at a genome-wide false discovery rate (FDR)
o0.05, we found six genes signiﬁcantly differentially expressed
between cases and controls after controlling simultaneously for
sex, age and population substructure via genotypic principal
components (Fig. 1). In order of the lowest to highest adjusted P
value, these genes were MRPS23 (mitochondrial ribosomal pro-
tein S23), DICER1 (DICER1, ribonuclease type III), CHST15
(carbohydrate N-acetylgalactosamine 4-sulfate 6-o sulfotransfer-
ase 15), ZXDC (ZXD family zinc ﬁnger C), PDCD5 (programmed
cell death 5), and LOC649548 (a pseudogene) (Fig. 1a). DICER1
had lower expression in cases relative to controls (F-test,
P¼ 7.93E 06, genome-wide adjusted P¼ 0.040, Fig. 1b).
Our a priori plan was to follow-up on the genes with the most
promising evidence of being involved in PTSD and depression
using a curated literature search approach. We decided to
examine DICER1 more closely for several reasons. First, DICER1
is a conserved ribonuclease enzyme that processes precursor
RNAs into mature short-interfering RNAs and miRNAs9,12,
which regulates the expression of thousands of genes
post-transcriptionally and involve in synaptic development,
maturation and plasticity13,14. Second, DICER1 expression was
twofold reduced in the temporal cortex of patients with major
depressive disorder relative to controls7. Third, regulation of
expression of DICER1 and miRNAs in the nucleus accumbens
was found to be important in mediating vulnerability or resilience
to stress in a chronic social defeat mouse model8. Lastly, studies
have shown that decreasing DICER1 expression in human
peripheral cell lines stimulated the innate immune system via
the upregulation of the major histocompatibility complex class
I-related molecules15, and causal signatures for PTSD
development was enriched for functions of the innate immune
response in a prospective transcriptomic study16.
Next, since gene expression proﬁles can be affected by alcohol
use, drug use, other psychiatric disorders or proportion of blood
cell counts, we performed a secondary analysis in a subset of
participants who had data on all of these variables. To that end, in
a subset of 121 participants of the GTP discovery cohort, we
performed genome-wide differential gene expression analysis
between cases of PTSD&Dep and controls, adjusting simulta-
neously for sex, age, genotypic principal components, current
alcohol and drug use disorders, bipolar disorder, current
psychotic disorder and estimated cell counts. Consistent with
our DICER1 result from the primary analysis, we found that at
genome-wide FDRo0.05, DICER1 was signiﬁcantly downregu-
lated in cases compared with controls (F-test, P¼ 0.0001,
adjusted P¼ 0.048), suggesting that the reduced expression of
DICER1 in the cases was not likely due to effects of drug or
alcohol use, other psychiatric disorders or variation in immune
cell proportions.
Subsequently we performed a validation of the downregulation
of DICER1 mRNA level in cases of PTSD&Dep compared with
controls with quantitative PCR (qPCR) and found consistent
results (1.3-fold downregulation in cases at t-test P¼ 0.001). Since
DICER1 expression was signiﬁcantly diminished in PTSD&Dep
after sex, age, population substructure, alcohol and drug use,
other psychiatric disorders and estimated blood cell count were
adjusted for, we focused on DICER1 expression, as reﬂected by
the normalized intensity of the ILMN_1772692 probe, for follow-
up studies. Hence, the genetic and imaging studies described in
subsequent sections are targeted, hypothesis driven analyses to
follow-up on our DICER1 expression ﬁnding.
DICER1 SNPs versus DICER1 expression in blood. Given our
ﬁnding of reduced DICER1 expression in cases of PTSD&Dep
versus controls, we next asked which single-nucleotide
polymorphisms (SNPs) of the DICER1 gene might inﬂuence its
blood mRNA level. In our discovery GTP sample, the Illumina
HumanOmni1-Quad BeadChip generated 14 DICER1 tagging
SNPs after standard genotype quality control as described in
Methods. Out of these 14 SNPs, two were located in the coding
regions, four in the 30UTR and eight in the intronic regions. We
found three SNPs signiﬁcantly associated with DICER1
expression level after controlling for sex and the principal
components: rs10144436 (Wald test P¼ 0.0034; n¼ 191),
rs1209904 (Wald test P¼ P¼ 0.0018; n¼ 191) and rs11160231
(Wald test P¼ 0.0082; n¼ 191). After we performed permutation
to adjust for multiple testing17, only two SNPs remained
signiﬁcantly associated with DICER1 expression: rs10144436
(P¼ 0.0034; adjusted P¼ 0.0452) and rs1209904 (P¼ 0.0018;
adjusted P¼ 0.0277). These two eQTLs were in linkage
Volcano plot for genome-wide differential expression profiles
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Figure 1 | Genome-wide differential gene expression proﬁles in
PTSD&Dep cases vs controls. (a) Volcano plot for genome-wide
differential gene expression proﬁles between cases of PTSD&Dep and
controls, adjusting for sex, age and population substructure. The red line
represents P value at FDR of 0.05 ( log10p¼4.729). The blue dots
represent genes signiﬁcantly differentially expressed between cases and
controls. These genes are MRPS23, DICER1, CHST15, ZXDC, PDCD5 and
LOC649548. Cases had reduced DICER1 expression compared with
controls. (b) Box plot for DICER1 expression level in cases of PTSD&Dep and
controls. The horizontal line represents the mean DICER1 level in the overall
sample. These were derived from expression microarrays.
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disequilibrium with each other at D’¼ 0.98 and r2¼ 0.05.
Speciﬁcally, rs1209904 is an intronic SNP and its minor allele
(T) was associated with decreased DICER1 expression. The other
SNP, rs10144436, is located in the 30UTR of DICER1 and its
minor allele (A) was also associated with lower DICER1 mRNA
level (Fig. 2a).
DICER1 eQTLs versus PTSD&Dep phenotype. Having
identiﬁed two DICER1 eQTL SNPs, rs10144436 (minor allele
frequency (MAF)¼ 0.098, Hardy–Weinberg equilibrium (HWE)
P value¼ 0.93, minor allele¼A) and rs1209904 (MAF¼ 0.337;
HWE P value¼ 0.03, minor allele¼T), we next examined
whether they were associated with PTSD&Dep in our 1876 all
African American participants. Out of these two SNPs, only one,
rs10144436, was signiﬁcantly associated with PTSD&Dep after
sex and population substructure via principal components were
adjusted for (odds ratio¼ 1.32, Wald test P¼ 0.012, Bonferroni-
adjusted P¼ 0.024; n¼ 1,874). Its minor allele (A) was associated
with higher risk for PTSD&Dep. This is consistent with the
expression ﬁnding, in which the minor allele of rs10144436 was
associated with lower DICER1 expression level, which was also
associated with PTSD&Dep (Fig. 2b).
Gene set enrichment analysis (GSEA) in PTSD&Dep. We
next performed gene set enrichment analysis (GSEA)18 to gain
insights into biological processes involving the differentially
expressed genes in PTSD&Dep. Genes differentially expressed at
P valueso0.01 (P values ranged from 0.0098 to 7.92E 07) were
included in the GSEA. We found many gene sets signiﬁcantly
enriched at FDR of 0.05 (Supplementary Table 1). Given the
critical role of DICER1 in the formation of mature miRNAs, it is
notable that 13 sets of genes that were targets of various miRNAs
and one set involving brain miRNA biogenesis in a mouse model
of schizophrenia were signiﬁcantly enriched, suggesting that
genes that are targets of different miRNAs were differentially
expressed in PTSD&Dep (Supplementary Table 1). Additionally,
three gene sets related to the immune system were enriched: (a)
genes involved in cytokine signalling, (b) genes upregulated in
polymorphonuclear leukocytes after Francisella tularensis
vaccination in human and (c) genes involved in the innate
immune system (Supplementary Table 1).
microRNA regulation in PTSD&Dep. Given the above GSEA
results and our DICER1 expression and genotype ﬁndings, which
were replicated in three independent cohorts as described in the
subsequent sections, we aimed to obtain more evidence towards
our hypothesis that the DICER1 and the miRNA pathway is
involved in molecular mechanisms of PTSD&Dep by measuring
blood miRNA levels in PTSD&Dep cases and controls. Using an
RNA extraction protocol that preserves total RNA, we had 78
participants with available small RNAs and PTSD&Dep case or
control status. We randomly selected 24 participants out of these
78 for a discovery sample, and the remaining 54 participants
served as the replication sample. There was no difference in
percentage of case status or percent of female between the 24 and
78 participants (Fisher Exact Test P¼ 0.805 for percent of case
status; P¼ 0.800 for percent of female).
We next generated small RNA libraries for the discovery
sample to perform small RNA sequencing. After standard quality
control as described in Methods, we performed genome-wide
differential miRNA expression analysis using DESeq2 (ref. 19),
adjusting for sex, age and genotypic principal components. All 24
participants were African American, and there were 7 controls
and 17 cases of PTSD&Dep. At genome-wide FDRo0.05, two
miRNAs were signiﬁcantly differentially expressed, and both
were downregulated in the cases compared with the controls
after sex, age and genotypic principal components were
adjusted for: miR-212-3p (log2 fold change¼  1.72; Wald test
P¼ 4.48E 05, adjusted P¼ 0.048) and miR-3130-5p (log2 fold
change¼  1.61; Wald test P¼ 4.97E 05, adjusted P¼ 0.048;
Fig. 3a,b).
The replication sample had 54 participants, all of whom were
African American and 20 were controls and 34 were cases. Using
qPCR, we examined the two miRNAs having adjusted Po0.05
above in the replication sample. We found that miR-3130-5p was
signiﬁcantly downregulated, with 1.57-fold downregulation, in
the PTSD&Dep cases relative to controls after sex, age and
genotypic principal components were adjusted for (b¼ 0.284;
w2-test P¼ 0.030; Fig. 3c). There was no signiﬁcant association
between miR-212-3p and PTSD&Dep in the replication sample.
Of great interest, these two miRNAs have been studied in other
neuropsychiatric disorders as described further in Discussion.
DICER1 and miRNA regulation in PTSD&Dep. Using miRDB
(miRDB.org), we identiﬁed 138 mRNAs that are potential targets
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of the miR-3130-5p at target score Z60 (list A, a.k.a
Supplementary Table 2). From our original genome-wide
differential gene expression analysis, 59 mRNAs were upregulated
in the PTSD&Dep cases versus controls at FDRo0.1 (list B, a.k.a
Supplementary Table 3). Since DICER1 expression was reduced in
the cases, we infer that levels of mature miRNAs in the cases
would be reduced, and as the result, levels of their corresponding
mRNA targets would be increased in the cases. The intersection
of the list A (potential mRNA targets of miR-3130-5p) and list B
(59 upregulated mRNAs in the cases) yielded one overlap:
MRPL35 (mitochondrial ribosomal protein L35). In this proof-of-
concept study we found that in the cases of PTSD&Dep DICER1
expression level was reduced, and consistently at least one mature
miRNA had decreased abundance level, and one of its
corresponding mRNA target had increased expression level
relative to controls. Since miRNA-mediated gene silencing of
targeted mRNA occurs through a combination of translational
repression, mRNA deadenylation, decapping and decay12, it is
not surprising that only a limited number of mRNA targets
changed their abundance at the mRNA transcript level. In sum,
this novel data support the notion that DICER1 and the
miRNA pathway is implicated in molecular mechanisms of
PTSD&Dep.
Neural correlates of DICER1 gene expression. As our primary
interest was to understand mechanisms underlying effects of
DICER1 expression on symptoms of PTSD and depression, we
investigated how DICER1 blood mRNA level might be related to
neural responses to threat stimuli using fMRI. Speciﬁcally, we
conducted a whole-brain analysis of linear correlation between
DICER1 expression levels and the contrast of fearful4neutral
face stimuli in a subset of 28 traumatized women who provided
both blood mRNA and fMRI data (Fig. 4, Table 2). Whole-brain
analysis showed an inverse correlation between DICER1 expres-
sion and activation in the right medial prefrontal cortex, bilateral
temporal cortex, right posterior parietal cortex and cerebellum.
No region correlated positively with DICER1 expression levels.
Since functional neuroimaging evidence has shown involvement
of the amygdala, particularly its increased activation, in
PTSD20,21, we selected this region for further examination.
Amygdala region of interest analyses indicated a cluster in the
right amygdala that correlated negatively with DICER1 expression
level (x, y, z¼ 28,  4,  28; Z¼ 2.19; k¼ 11). No part of the
amygdala showed a positive correlation with DICER1 expression.
In sum, we found that lower DICER1 expression level was
signiﬁcantly associated with more amygdala activation to fearful
stimuli, an intermediate phenotype for PTSD, which is consistent
with our above ﬁnding of lower DICER1 expression being
associated with PTSD&Dep.
Replication of reduced DICER1 expression in PTSD&Dep. We
examined DICER1 expression level in the Detroit Neighborhood
Health Study (DNHS) cohort of 111 participants, out of whom 15
were cases of current PTSD (and 60% of these cases had
comorbid current depression) and 96 were controls with no
current PTSD and no current depression. Mean age among cases
and controls was 48.5±12 and 54.7±15.4, proportion of female
was 60% and 52%, percentage of African Americans was 66.7%
and 86.5%, of European Americans was 33.3% and 12.5%, and of
other ethnic group was 0 and 1.0%, respectively. Blood DICER1
expression level, as reﬂected by normalized intensity levels of the
ILMN_1772692 probe, was signiﬁcantly reduced in cases relative
to controls (b¼  0.138, s.e.m.¼ 0.062, F-test P¼ 0.029) after
sex, age and self-reported race were controlled for in a linear
regression model (Fig. 5a). In a subset of 94 participants in whom
we had principal components derived from genome-wide
genotypes, DICER1 expression continued to be signiﬁcantly
reduced in cases compared with controls after sex, age and
principal components were adjusted for (b¼  0.180,
s.e.m.¼ 0.072, F-test P¼ 0.014). This DICER1 expression
ﬁnding is consistent with, and thus replicated, our
ﬁnding of reduced DICER1 blood expression level in cases of
PTSD&Dep.
Replication of reduced DICER1 expression in another sample.
We searched the publicly available datasets deposited in the
Gene Expression Omnibus (GEO, in January of 2015) and
found a relevant study on blood gene expression in a stressed
cohort by Miller et al.22 (GSE7893). The authors investigated
effects of severe psychological stress on transcriptional control
pathways by surveying genome-wide differential gene expression
proﬁles of caregivers of family members with aggressive
brain tumours and matched controls22. The caregivers had
signiﬁcantly higher psychological distress, as reﬂected by
higher perceived stress score (t-test P¼ 0.003), decreased
1.5
a
c
b
500.0
100.0
50.0
20.0
10.0
5.0N
or
m
al
iz
ed
 c
ou
nt
2.0
1.0
0.5
Control
Control
Status
Case
Case
Group
1.0
0.5
0.0
–0.5
Lo
g 
fo
ld
 c
ha
ng
e
–1.0
–1.5
6
5
4
N
or
m
al
iz
ed
 th
re
sh
ol
d 
cy
cle
 fo
r
m
iR
31
30
3
1e–01
Genome wide differential miRNA
expression in PTSD&Dep hsa-miR-3130–5p
1e+01
Mean expression
miR-3130 expression is lower in
cases vs. controls
1e+03
Figure 3 | miRNA levels in PTSD&Dep cases vs. controls in the discovery
(n¼24) and replication sample (n¼54). (a) MA plot for genome-wide
differential expression of miRNAs in the discovery sample. The two points
coloured in red are the two miRNAs with genome-wide adjusted P
valueo0.05 (miR-212-3p and miR-3130-5p). (b) miR-3130-5p expression
was signiﬁcantly lower in cases vs. controls in the discovery sample after
sex, age and principal components were adjusted for. (c) miR-3130-5p
expression was signiﬁcantly downregulated in cases vs. controls in the
replication sample after sex, age and genotypic principal components were
adjusted for (P¼0.030). Note, higher threshold cycle (CT) indicates lower
abundance level. Error bar represents one s.e.m.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10106 ARTICLE
NATURE COMMUNICATIONS | 6:10106 | DOI: 10.1038/ncomms10106 | www.nature.com/naturecommunications 5
satisfaction with life (t-test P¼ 0.04), and fewer positive emotions
(t-test Po0.004) compared with controls22. Controls were
matched for age, gender, ethnicity, marital status, cigarette
and alcohol use, exercise, sleep habits, body mass index and
history of cardiovascular diseases, as well as being free of
major stressors such as divorce, bereavement, unemployment
and family illness during the prior year22. Study subjects
were recruited from the British Columbia in Vancouver. We
downloaded the data and performed a secondary analysis
on DICER1 expression in this sample and found that DICER1
expression was reduced in stressed cases versus controls
(b¼  0.54, t-test P¼ 0.04, Fig. 5b). Further reading of
the study publication conﬁrmed our ﬁnding, as DICER1
was listed in Supplementary Table S1 in the supplemental
data as underexpressed in stressed cases versus controls
at an expression ratio of 0.47 and Po0.05. Assessment of
PTSD was not done in this study; however, we think the severe,
chronic and traumatizing stress caregivers experienced is
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Figure 4 | Lower DICER1 expression in blood is signiﬁcantly associated with more activation of the right amygdala in response to fearful faces, an
intermediate phenotype for PTSD. Regions in which the response to threat (fearful4neutral face stimuli) correlated negatively with expression, Po0.05,
corrected. (a) Clusters showing a signiﬁcant correlation with expression in whole-brain analysis. Correction for multiple comparisons used a combined
height-extent threshold calculated using Alphasim Monte-Carlo simulation, with 1,000 iterations and a cluster-forming threshold of Po0.01. (b) A
signiﬁcant negative correlation with expression in the amygdala region of interest (ROI). Amygdala ROI analyses used a small-volume correction
implemented in Alphasim, with 1,000 iterations and a cluster-forming threshold of Po0.05. Scatter plot shows the average contrast estimate for the
fear4neutral contrast, from voxels in the activated cluster. Images are shown in neurological orientation, overlaid on a single-subject template in Montreal
Neurological Institute (MNI) space.
Table 2 | Whole-brain analysis of linear correlation between DICER1 expression level and the contrast of fearful4neutral face
stimuli in 28 female participants.
MNI coordinates
Region HEM x y z Z k
Positive correlation with DICER1 expression
No signiﬁcant clusters
Negative correlation with DICER1 expression
Sup. frontal G. R 20 68 8 4.27 211
Orbitofrontal G. R 16 44 8 3.23 (LM)
Sup. frontal G. R 12 52  24 2.56 (LM)
Sup. temporal G. R 60  16 4 3.27 85
Sup. temporal G. R 68  28 20 3.01 (LM)
Supramarginal G. R 64  20 44 2.9 (LM)
Mid. temporal G. L  64  32 8 3.17 53
Sup. temporal G. L 44  36 8 2.77 (LM)
Sup. temporal G. L 48 40 20 2.45 (LM)
Mid. temporal G. R 56 68 12 2.91 22
Angular G. R 48 68 44 3 27
Angular G. R 48  72 36 2.97 (LM)
Cerebellum L 4 44 8 2.59 24
Cerebellum L 8  52 8 2.48 (LM)
MNI, Montreal Neurological Institute; HEM, Hemisphere; LM, Local Maximum.
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arguably consistent with stress-related PTSD and depression. This
ﬁnding is consistent with our ﬁnding of decreased DICER1
expression in cases of PTSD&Dep.
Replication of association between DICER1 eQTL and
PTSD&Dep. Here, we examined the association between the
DICER1 eQTL rs10144436 and PTSD&Dep in the Drakenstein,
South African cohort. The Drakenstein cohort consists of
pregnant women recruited from the peri-urban community of the
Drakenstein subdistrict in South Africa. There is a high
prevalence of trauma exposure in these at-risk women who were
assessed longitudinally for trauma-related psychiatric disorders23.
Post-traumatic stress disorder was assessed with the modiﬁed
PTSD symptom scale (PSS)24 and the MINI10. Among the 380
participants with available genome-wide genotype markers from
the PsychArray chip, there were 134 cases with lifetime PTSD and
246 controls with no lifetime PTSD. Among the 134 PTSD cases,
B64% also had signiﬁcant depression in their lifetime, as assessed
by the MINI10 or having a score ofZ14 on the Beck Depression
Inventory (BDI)25,26. There were 60.4% Black and 39.6% mixed
race among the cases and 56.1% Black and 43.9% mixed race
among the controls. In this cohort, the DICER1 rs10144436 had
an MAF of 0.101, HWE P value of 0.82, and A as the minor allele.
We found that rs10144436 was signiﬁcantly associated with
lifetime PTSD after population substructure was controlled for
via principal components from genome-wide genotype markers
(odds ratio¼ 1.877, Wald test P¼ 0.008, n¼ 380). Consistent
with our ﬁnding, the minor allele of rs10144436 was associated
with increased risk for PTSD (Fig. 5c). Gene expression data are
not available for this cohort.
Discussion
Post-traumatic stress disorder with comorbid depression is highly
prevalent among susceptible individuals following traumatic life
events6. Here, we surveyed genome-wide differential gene
expression proﬁles in blood in cases of PTSD&Dep and
controls with no PTSD and no depression. We found that
DICER1 mRNA level was signiﬁcantly reduced in the cases
relative to the controls after we adjusted simultaneously for sex,
age, population substructure, current alcohol and drug use
disorders, current psychotic disorder, bipolar disorder and
estimated blood cell counts. Importantly, downregulation of
DICER1 expression in PTSD&Dep was replicated in two
independent cohorts, the DNHS27 and the Vancouver
caregivers for family members with aggressive malignant brain
cancer22. Consistently, our follow-up fMRI study found that
lower DICER1 blood mRNA level was signiﬁcantly associated
with increased amygdala activation to fearful stimuli, a neural
correlate for PTSD. Furthermore, we found that a DICER1 eQTL,
rs10144436, located in its 30UTR, was signiﬁcantly associated with
PTSD&Dep, and this association was replicated in a South
African cohort of lifetime PTSD cases and controls23. Taken
together, we infer that DICER1 plays a role in the mechanism or
manifestation of PTSD&Dep.
DICER1 is a highly conserved RNAse III enzyme that is crucial
for the biogenesis of noncoding, regulatory small RNAs,
including miRNAs and short-interfering RNAs, in different
tissues including the brain8,9,12. Speciﬁcally, DICER1 converts
precursor miRNAs to mature miRNAs, which not only ﬁne-tune
expression of thousands of genes via post-transcriptional
repression in various tissues, including the nervous system but
also involve in synaptic development, maturation and
plasticity13,14. A growing number of studies have suggested
the involvement of miRNAs in major depressive disorder,
stress-related disorders and other psychiatric disorders28–30.
Consistently, in our proof-of-concept study, we found that at
least one miRNA, miR-3130-5p, had signiﬁcantly reduced
abundance level in the PTSD&Dep cases in both the discovery
and replication samples, and one of its mRNA targets was
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Figure 5 | Replication of reduced DICER1 expression level in. (a) The
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upregulated in the PTSD&Dep cases versus controls after we
controlled for sex, age and population substructure. Taken
together, our ﬁndings support the notion that the DICER1 and
the miRNA pathway plays a role in the pathogenesis or
manifestation of PTSD&Dep, potentially by regulating
expression of the corresponding downstream mRNA targets
and inﬂuencing cellular responses.
Of note, miR-3130 has been reported in other neuropsychiatric
disorders. Speciﬁcally, a genome-wide association study of
memory and hippocampal structure of 14,781 older adults found
a genome-wide signiﬁcant SNP that is located in the intronic
region of the FASTKD2 gene that is overlapped by miR-3130
(ref. 31). Although not replicated in our replication sample, miR-
212 has been studied in Alzheimer’s disease patients32. That study
found that decreasing or increasing miR-212 expression in the
temporal cortex and hippocampal neurons could induce
apoptosis or neuroprotective effects respectively against
oxidative stress32.
Stress-related DICER1 and miRNA regulation in blood and
brain may occur in parallel in human subjects, as our
stress-related DICER1 and miRNA ﬁndings in blood are consistent
with stress-related DICER1 and miRNA ﬁndings in the nucleus
accumbens, a brain region involved in motivation, pleasure,
reward, reinforcement learning and addiction, in a chronic social
defeat stress mouse model8. In this study, Dias et al.8 found that
b-catenin mediated vulnerability or resilience to stress through
DICER1 and miRNA regulation in the nucleus accumbens.
Speciﬁcally, the authors found that DICER1 was a robust target
of b-catenin, that mice with DICER1 knockdown (thus reduced or
absent DICER1 mRNA level) was easily susceptible to stress, and
that in resilient mice, b-catenin turned on DICER1 transcription8.
Our ﬁnding is also consistent with another mouse study in which
depletion of DICER1 in the central amygdala led to an increase in
anxiety-like behaviour, and that after acute restraint stress,
expression proﬁles of miRNAs in the amygdala were changed33.
Our ﬁndings are also in line with two human studies, in which
DICER1 expression was twofold reduced in the temporal cortex of
patients with major depressive disorder relative to controls7, and
global miRNA expression was reduced in the prefrontal cortex of
depressed suicide completers relative to controls34.
Interestingly, DICER1 mRNA level was found to be upregu-
lated in lymphoblastoid cell lines of schizophrenia patients35 and
also upregulated in the dorsolateral prefrontal cortex of
schizophrenia patients36, suggesting the possibility of a positive
correlation of DICER1 expression between blood and brain;
however, this remains to be investigated.
Given these ﬁndings, studies are needed to elucidate mechan-
isms linking the regulation of DICER1 and miRNA in blood to
that in the brain as well as to complex neurobehavioral
phenotypes of PTSD and depression in humans. We hypothesize
that this occurs via multiple pathways, and one potential pathway
is the brain-immune interactions given the connection between
DICER1 expression and the innate immune system15,37,38.
Speciﬁcally, decreased DICER1 expression in human peripheral
tissues (that is, embryonic kidney, dermal foreskin ﬁbroblast or
lung-tissue ﬁbroblast) induces a DNA damage response, which
stimulates the innate immune response by upregulation of the
major histocompatibility complex class I-related molecules A
and B15,37,38. The activated innate immune system creates a
pro-inﬂammatory state, recruiting and activating neutrophils, and
releasing cytokines from activated macrophages, among other
processes39. A chronic inﬂammatory state, including elevated
levels of pro-inﬂammatory cytokines or activated monocytes, has
been shown to contribute to anxiety and depressive disorders by
affecting metabolism of neurotransmitters in the brain or via
monocyte trafﬁcking to the brain in both mice and human
studies40–42. Another potential mechanism is the regulation of the
tightness or leakiness of the blood–brain barrier (BBB) by central
or peripheral miRNAs43,44. A recent study of the mechanism of
migration of breast cancer cells through the BBB in brain
metastasis suggests that breast cancer cells with high metastatic
capacity release extracellular vesicles containing proteins and
miRNAs that can trigger the breakdown of the BBB44.
Particularly, the study authors found that miR-181c in these
peripheral tissue promotes the destruction of the BBB by
regulating the actin dynamics44.
Prospective studies observed an increased risk of early-age
cardiovascular disease, such as early-onset heart disease, stroke
and myocardial ischaemia, in PTSD patients45,46. The
involvement of DICER1 and the miRNA pathway in PTSD is
consistent with the overall psychosomatic picture of PTSD
reported by these epidemiological studies, since both DICER1 and
miRNAs have been implicated in cardiovascular diseases. For
instance, dysregulation of DICER1-dependent miRNA expression
has been suggested to be a potential mechanism of impaired
angiogenesis47 and impaired vascular remodelling48. Likewise,
miRNAs have been shown to control important processes that
contribute to cardiac hypertrophy, myocardial infarction,
neovascularization, cardiac ﬁbrosis, arrhythmia, angiogenesis
and cholesterol regulation49,50.
Several studies have linked PTSD to increased activation of the
amygdala to negative or fearful stimuli20,21. Here we found that
decreased DICER1 expression in blood was associated with
greater amygdala reactivity to threat stimuli and to PTSD and
depression symptom severity. Additionally, we found that
diminished DICER1 expression was associated with increased
activation of the posterior parietal cortex, which engages in a host
of cognitive functions including selective attention51. This is
consistent with ﬁndings from another study, where war and
torture survivors suffering from PTSD had hyperactivation of the
superior parietal cortex selectively in response to aversive
stimuli52. We also found an inverse correlation between
DICER1 expression and activation of the medial prefrontal
cortex, which is not consistent with what is typically observed in
PTSD20. However, this ﬁnding is consistent with hyperactivity of
the medial prefrontal cortex during the self-referential processing
of negative words in major depressed patients relative to
controls53. Our fMRI sample included women having been
exposed to traumatic experiences and developed high levels of
PTSD and depression, and thus our neuroimaging DICER1
ﬁndings are speciﬁc to this sample of participants; inﬂuence of
DICER1 expression on brain activation might be different in
healthy participants. In future research, it would be interesting to
investigate potential effects of DICER1 expression on threat-
processing circuitry using structural connectivity measures such
as diffusion tensor imaging.
Our study has some limitations that should be taken into
consideration when interpreting the results. Speciﬁcally, we did
not have information on medications and tobacco use to control
for in the gene expression analyses as they may inﬂuence gene
expression proﬁles. We also did not assess for generalized anxiety
disorder, social anxiety disorder or panic disorder to adjust for in
the differential analysis. Additionally, the replication samples for
DICER1 expression level, the DNHS and caregiver samples, have
relatively small sample sizes and thus higher potential for
technical variation. Further, our genome-wide expression proﬁl-
ing of miRNAs was done in a small sample and thus likely lack
the power to discover more miRNAs differentially regulated
between PTSD&Dep cases and controls. A larger sample size is
needed to discover more miRNAs differentially expressed in
stress-related disorders such as PTSD or PTSD&Dep. Lastly, the
observed differential expression of DICER1 in PTSD&Dep could
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be reﬂective of an underlying genetic or epigenetic mechanism or
a combination of both. Here, we presented evidence for an
underlying genetic mechanism by showing a signiﬁcant asso-
ciation between a polymorphism on the 30UTR of DICER1,
rs10144436, and PTSD&Dep. Even though this association
remained signiﬁcant after multiple testing corrections and was
replicated in an independent South African cohort, it is worth
mentioning that our ﬁnding still remains at the level of candidate
gene analysis and not genome-wide association. Stronger
evidence at the genome-wide association level is needed to
conﬁrm that a genetic mechanism underlies the association
between DICER1 expression and PTSD&Dep. It would be
interesting for future studies to investigate the hypothesis that
epigenetic mechanisms underlie the association between differ-
ential expression of DICER1 and PTSD&Dep.
In summary, this is the ﬁrst human study to our knowledge to
suggest that DICER1 and the miRNA regulation pathway are
implicated in biological mechanisms of PTSD with comorbid
depression. Studies are needed to elucidate the relationship
between blood and brain DICER1 and miRNA regulation
as well as mechanisms underlying the connection between
blood DICER1 and miRNA regulation and stress-related
psychiatric disorders to contribute to their prevention and
treatment efforts.
Methods
Grady trauma project study participants. This study was part of a larger GTP
investigating genetic and environmental factors contributing to PTSD in a
population of inner city, low income and high stress and trauma exposed
individuals. Inclusion criteria consisted of being 18 or older, understanding English
and being able to give informed consent. Exclusion criteria included being acutely
suicidal, psychotic or having acute medical problems. Participants gave informed
consent, completed a battery of psychological measures and provided blood for
genetic materials. This study has been approved by the Institutional Review Board
of Emory University School of Medicine and Grady Memorial Hospital. A total
of 184 men and women were included in this study based on availability of
gene expression proﬁles and principal components derived from genome-wide
genotype markers, and meeting the criteria for PTSD with comorbid depression
(PTSD&Dep) as described in detail below. A subset of these participants was
reported in a previous study focusing on childhood maltreatment and PTSD54.
PTSD with comorbid depression (PTSD&Dep) phenotype. PTSD was assessed
with the modiﬁed PSS, a psychometrically validated, 18-item self-report scale with
excellent internal consistency, high test-retest reliability and concurrent validity, as
well as mirroring the DSM-IV criteria for PTSD24. A PSS cutoff score of 14 yields
a sensitivity of 91% and speciﬁcity of 62% for identifying PTSD when compared
with the diagnosis of PTSD made by the clinician-administered PTSD scale in
229 motor vehicle accident survivors55. Hence, we operationally deﬁned PSS
scores Z14 to indicate clinically signiﬁcant current PTSD symptoms.
Depressive symptoms were measured with the psychometrically validated
21-item BDI25. The BDI has an excellent internal consistency (reliability coefﬁcient
of 0.93) and is commonly used in depression research studies25. Among African
American primary care patients, a BDI cutoff score of 14 yielded a sensitivity of
88% and speciﬁcity of 84% when compared with a diagnosis of MDD made by
PRIME-MD Mood Module, a focused interview for MDD using DSM-IV criteria26.
Given these data and that 94% of our study participants are African Americans, we
used a BDI score Z14 to indicate clinically signiﬁcant current depression.
Cases of current PTSD&Dep were deﬁned as having both a PSSZ14 and
BDIZ14. Controls were deﬁned as not having either signiﬁcant PTSD or
depression, as reﬂected by a PSSr7 and BDIr7. There were 112 cases of current
PTSD&Dep and 72 controls in this study.
Other psychiatric disorders. Current alcohol or drug use disorder, bipolar
disorder and current psychotic disorder were assessed using the SCID11 or MINI10,
and was available in a subset of 145–150 participants.
Gene expression proﬁles in the GTP cohort. RNA was extracted from whole
blood collected in Tempus tubes at about 0830 h for all participants. All samples
had Bioanalyzer RNA Integrity Number (RIN) Z6. Complementary DNA was
derived from RNA and then hybridized, and raw probe intensities were generated
on Illumina HumanHT-12 v3 or v4 BeadChip arrays. Probes with detection
P value40.01 in at least 95% individuals were ﬁltered out, leaving 15,877 probes
from the v3 chip and 17,048 probes from the v4 chip. Combining probes from v3
and v4 chips yielded 13,048 probes in common to be included in the analysis.
We then performed log2 transformation and normalization of probe intensities
using the Supervised Normalization of Microarray algorithm, removing the effects
of batch and RIN56. The gene expression data set has been deposited at the Gene
Expression Omnibus with the accession number GSE67663.
Genotypes and principal components in the GTP cohort. DNA was extracted
from saliva or blood, and genome-wide SNP genotyping was conducted using
Illumina’s HumanOmni1-Quad or OmniExpress BeadChips. Standard quality
control of the genome-wide data was performed using PLINK57, removing
individuals with greater than 2% missing data and removing one in each pair of
related individuals with an identity by descent proportion40.12 (indicating
cousins or a closer relation). We removed SNPs with call ratesr 98%, MAFo0.01,
and HWE P valueo1 10 6 in PTSD controls. After restricting the SNPs to the
autosomes, we used PLINK to prune the data in windows of 50 base pairs,
removing one SNP from each pair of SNPs with r240.05 to obtain a set of roughly
independent SNPs. This reduced set of SNPs was used in principal component
analysis to infer axes of ancestry and remove outlier subjects58. The gene
expression analysis utilized the principal components generated from combined
genome-wide data from the two chips (HumanOmni1-Quad and OmniExpress) on
the subset of subjects with expression data. The candidate gene analysis was
conducted using DICER1 SNPs genotyped on the HumanOmni1-Quad Beadchip
only, with similar quality control as described above (African American only,
n¼ 1,874 meeting deﬁnition of PTSD&Dep cases and controls).
Genome-wide differential gene expression analysis in GTP cohort. Genome-
wide differential gene expression between cases of current PTSD&Dep and controls
was surveyed using analysis of covariance, in which normalized gene expression
level for each probe was the outcome, PTSD&Dep the dichotomous independent
variable, sex, age and genotypic principal components as the covariates. Age was
categorized into three groups, below 33rd percentile, from 33rd to 67th percentile
and above 67th percentile. The ﬁrst ﬁve principal components, described above,
were used as covariates to control for population substructure. Multiple testing was
accounted for with the Benjamini and Hochberg FDR of 0.05 (ref. 59). Analyses
were performed using JMP Genomics version 7.
GSEA. To gain insight into biological processes involving the differentially
expressed genes between cases and controls, we performed GSEA using the
pre-ranked GSEA analytical software from the Broad Institute18. Genes that were
differentially expressed between cases and controls at genome-wide FDRo0.20
(that is, genes with nominal P values ranging between 5.97E 07 and 0.0098,
n¼ 658 genes) were pre-ranked using their t-statistics derived from the analysis of
covariance for differential expression between cases and controls as described
above. Gene sets were obtained from the Molecular Signature Database (MSigD)
v4.0 (ref. 18). We selected the gene sets from the curated, gene ontology, positional,
motif, computational, oncogenic and immunologic signatures collections,
particularly those with at least 15 genes in common with our pre-ranked gene list,
and the weighted p option (P¼ 1) for the running sum statistics for enrichment
score. Pre-ranked GSEA assessed the signiﬁcance for each gene set using 5000
permutations of case and the control status for each set, and multiple hypothesis
testing was adjusted with Benjamini and Hochberg FDR18,59.
Cell count estimate. Cell type proportions were estimated from genome-wide
DNA methylation data from blood samples drawn at the same visit as that used for
the expression arrays. The proportions of granulocytes and lymphocytes in each
sample were estimated using publically available data (GSE36069) and the method
described by Houseman et al.60,61.
qPCR validation of DICER1 differential expression in PTSD&Dep. In a subset of
40 subjects (20 cases of PTSD&Dep and 20 controls), whose RNA was run on the
Illumina HumanHT12 Beadchip arrays, total RNA from whole blood was reverse
transcribed into cDNA using the RT2 First Strand Kit (Qiagen). DICER1 and
GAPDH as housekeeping control were detected and quantiﬁed in duplicates using
the TaqMan assays Hs00229023_m1 (DICER1) and Hs02758991_g1 (GAPDH)
with TaqMan Gene Expression Master Mix on a ViiA7 real-time PCR system in
384-well format according to the instruction of the manufacturer (Applied Bios-
ciences). Gene expression differences and fold changes were calculated using the
2DDCt method62.
Candidate gene and eQTL analyses in the GTP cohort. Associations between
DICER1 SNPs and DICER1 expression levels were performed in PLINK using the
linear regression model, in which normalized DICER1 expression level was the
outcome, SNP genotype the independent variable and sex and the ﬁrst ﬁve
principal components as covariates. We used the additive model for SNP genotype,
with the minor allele coded as 1. Multiple testing was addressed with permuta-
tion17. Analyses for association between DICER1 tagging SNPs and PTSD&Dep
were performed in PLINK using logistic model, in which status of PTSD&Dep was
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the outcome, SNP genotype the independent variable and sex and the ﬁrst ﬁve
principal components as covariates. Likewise, we used the additive model for the
SNP genotype, with the minor allele coded as 1, and addressing multiple testing
with permutation17.
Small RNA sequencing and analysis in the GTP discovery sample. Total RNA
was extracted from whole blood, which was collected in Tempus tubes at 0830 h for
all participants, following the Norgen protocol (Norgen Biotek Inc.). Small RNA
was size fractionated from total RNA using polyacrylamide gel and then used as the
starting material to generate small RNA libraries following the Illumina TruSeq
Small RNA protocol. The 24 small RNA libraries were then multiplexed and
sequenced single-end reads on two lanes of the Illumina HiSeq1000.
Quality of the sequencing data was inspected with FastQC
(bioinformatics.babraham.ac.uk/projects/fastqc/). Adapters were trimmed
with cutadapt (https://cutadapt.readthedocs.org/en/stable/), and after trimming,
sequences shorter than 14 nucleotides were discarded. Read length distribution
after adapter trimming was visualized and observed to be centred at 22
nucleotides, indicating high-quality miRNA-seq library preparation63.
Trimmed reads were aligned to the miRBase v.21 (ref. 64) with SHRiMP aligner
((http://compbio.cs.toronto.edu/shrimp/), and only reads with a minimum average
PHRED score of 10 were considered for alignment. Percent reads mapped to
mature miRNAs ranged from 85 to 95%, indicating high-quality libraries and
sequencing data. The pipeline above was organized by the miRNA analysis
application65. After removing an outlier sample with an extremely low raw count
and four miRNAs with extremely high counts, genome-wide differential miRNA
analysis was performed using DESeq2 (ref. 19), adjusting for sex, age and ﬁve
genotypic principal components. Age was categorized into three groups, upper
third, middle third and lower third. Multiple testing was addressed with Benjamini
and Hochberg FDR19,59.
miRNA qPCR assays in the GTP replication sample (n¼54). Total RNA
extracted from whole blood was reverse transcribed into cDNA using Qiagen
miScript II RT kits and protocol. Hsa-miR-212-3p, hsa-miR-3130-5p and snRNA
RNU6B as housekeeping control were detected and quantiﬁed in triplicates using
Qiagen miScript Primer Assays Hs_miR-212_1, Hs_miR-3130-5p_1 and
Hs_RNU6-2_11 with miScript SYBR Green PCR kit on a ViiA7 real-time PCR
system in 384-well format according to the instruction of the manufacturer
(Qiagen). Normalized threshold cycle (CT) values and fold change for miR-212-3p
and miR-3130-5p were calculated using the 2DDCt method62. Differential
expression analysis for each of the two miRNAs was performed using a generalized
linear model in JMP Genomics, in which the normalized CT value was the
outcome, PTSD&Dep status the independent variable, and sex, age, and ﬁve
genotypic principal components as the covariates.
Functional MRI study in the GTP cohort. We examined neural correlates of
DICER1 expression in a functional MRI study among a subset of traumatized
women (n¼ 28) for whom we had both mRNA and fMRI data, drawn from
the larger GTP sample. Participants completed a task designed to engage threat-
processing networks via passively viewing static fearful and neutral face stimuli.
Blocks of either eight fearful or eight neutral face stimuli selected from the stimulus
set of Ekman and Friesen66 were presented in a pseudo-random order, with each
stimulus presented for 500ms. These fearful and neutral stimuli were sorted in
random order for each block. Participants were instructed to pay attention to the
faces but not make any behavioural responses to minimize motion artefacts, neural
activation unrelated to the processing of the visual stimulus, or dampening of
emotional arousal67. Brain imaging data were acquired on a Siemens 3.0 Tesla
Magnetom Trio TIM whole-body MR Scanner using a 12-channel head coil.
Pre-processing and statistical analyses were performed using Statistical Parametric
Mapping software (SPM5, Wellcome Trust Centre for Neuroimaging) and
AFNI (http://afni.nimh.nih.gov/afni/). Statistical contrasts between conditions
(for example, fearful versus neutral) were assessed with linear contrasts. First-level
models included fearful and neutral task conditions and six motion parameters.
Second-level models were conducted as a correlation between DICER1 expression
levels (continuous variable) and the contrast of fearful4neutral. Correction for
multiple comparisons was through a combined height-extent threshold calculated
using Alphasim Monte-Carlo simulation with 1,000 iterations and a cluster-
forming threshold of Po0.01 (ref. 68).
Detroit neighborhood health study (DNHS). In the DNHS cohort structured
telephone interviews were conducted to assess PTSD (with the PTSD Checklist
Civilian Version (PCL-C)) and depression (with the Patient Health Questionnaire
(PHQ-9))69. Post-traumatic stress disorder and depression diagnoses obtained
from the telephone interview responses have been validated in a random subsample
of participants via in-person clinical interview using the clinician-administered
PTSD scale and Structured Clinical Interview for DSM-IV Disorders, and the
comparison showed high internal consistency and concordance69.
Trained phlebotomists conducted venipuncture blood draws during scheduled
home visits to consenting participants. Following the blood draw, all blood samples
were sent to Wayne State University in Detroit, Michigan for processing. RNA was
isolated from leukocytes using Leukolocks kits (Ambion, Austin, TX) following the
manufacturer’s alternative protocol to preserve total RNA. All included samples
had RIN Z5, 28 s/18 sZ1.0 and 260/280 Z1.7. Illumina HT-12 V4 Expression
BeadChip was used to generate raw expression data, which was processed using the
Bioconductor (http://bioconductor.org) Limma and ComBat packages to
background correct, normalize and adjust for batch effects. The data was ﬁltered to
remove any low or unexpressed probes; after ﬁltration, 28,352 probes remained.
In a subset of 94 participants (out of 111) in this cohort we had principal
components derived from genome-wide genotypes. Participants’ DNA was isolated
from whole blood or saliva, and genome-wide genotypes were obtained using the
Illumina HumanOmniExpress BeadChips. A total of 688,890 SNPs passed quality
control ﬁlters, including call rate495%, MAF40.01, and HWE P41 10 6.
The Multidimensional scaling analysis of genome-wide identity-by-state data
implemented in PLINK was used to determine ancestry in the whole sample.
The ﬁrst two components from the multidimensional scaling analysis distinguished
African American from European American participants and others, and the
second component distinguished Hispanic from non-Hispanic participants70.
We therefore used the ﬁrst two principal components to adjust for population
substructure in the DICER1 expression replication analysis.
Drakenstein, South Africa cohort genotyping. Genome-wide genotype markers
for this cohort were obtained using the Illumina Inﬁnium PsychArray Beadchip.
Quality control of the genotypes was performed to exclude individuals with45%
missing data, SNPs with call rateso95%, SNPs with MAFo0.05, and SNPs with
HWE P valueo1 10 6 in controls ando1 10 10 in PTSD cases, as well as
removing duplicates and one in each pair of cryptically related individuals who had
an identity by descent proportion40.12 (indicating cousins or a closer relation).
Principal components were created using 40,000 random and independent
genome-wide SNPs. As only the ﬁrst principal component had the Tracy–Widom
test P valueo0.05, it was used as a covariate in the association analysis to adjust for
population substructure. DICER1 SNP rs10144436 was extracted from the above
genotypes to perform association analysis with lifetime PTSD in PLINK using
logistic model, co-varying for the ﬁrst principal component. All participants
were women (n¼ 380).
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